Home Celsion

Celsion

In operation
Targeted issuance
Innovative Cancer Treatment Product Developer

Basic Information

Celsion Corporation is a fully integrated oncology company with a highly promising portfolio of innovative cancer treatments. The company’s approach is an elegant method to deliver high concentrations of widely used anti-cancer drugs directly to the tumor site, maximizing efficacy while minimizing the side effects of systemic treatment, with the goal of improving patient outcomes for underserved cancer indications.
Celsion Corporation
NewJersey,United States of America
15~50 people
May 01, 2000
celsion@celsion.com